A Review on Adverse Drug Reactions
DOI:
https://doi.org/10.61427/jcpr.v1.i4.2021.46Keywords:
Adverse Drug reactions, Pharmacovigilance, PolypharmacyAbstract
Adverse Drug Reactions (ADRs) became as one of the global problems that affect both children and adults with varying intensities. A significant number of ADRs may occur in elderly due to the contribution of drug-drug interactions, who are under polypharmacy. Various definitions are available all over the world in case of ADRs. But the definition by the World health organization was well adopted and widely accepted by many countries across the world. To promote the identification and reporting of ADRs and also to ensure and enhance the patient safety certain measures has to be taken by all health care professionals. The contribution of health care professionals, in regard to ADRs database is very much important and has encouraged the ongoing certainty of benefit risk ratio of drugs and also contributed to detect the unusual ADRs which are undetected during the basic evaluation of the drug. Pharmacists have a vital role in the maintenance of drug safety by contributing towards the prevention, detection, documentation and reporting of ADRs. The hospital or clinical pharmacist should actively participate in the area of pharmacovigilence in order to strengthen the National pharmacovigilance program.
Downloads
References
Khan LM, Al-Harthi SE, Alkreathy HM, Osman AM, Ali AS. Detection of adverse drug reactions by medication antidote signals and comparison of their sensitivity with common methods of ADR detection. Saudi Pharm J. 2015;23(5):515-22.
Lazarou J, Pomeranz BH, Corey PN. Incidence of adverse drug reactions in hospitalized patients: a meta-analysis of prospective studies. JAMA. 1998; 279(15):1200–5.
Sriram S, Ghasemi A, Ramasamy R, et al. Prevalence of adverse drug reactions at a private tertiary care hospital in south India. J Res Med Sci. 2011; 16(1):16-25.
Naranjo CA. Busto U. Sellers EM, et al. A method for estimating the probability of adverse drug reactions. Clin Pharmacol Ther. 1981;30:239-45.
Campbell JE, Gossell-Williams M, Lee MG. A Review of Pharmacovigilance. West Indian Med J. 2014; 63(7): 771-4.
Getz KA, Stergiopoulos S, Kaitin KI. Evaluating the completeness and accuracy of MedWatch data. Am J Ther. 2014 Nov-Dec; 21(6):442-6. 7. Kalaiselvan V, Thota P, Singh GN. Pharmacovigilance Programme of India: Recent developments and future perspectives. Indian J Pharmacol. 2016 ;48(6):624-8.
Inman WH: Attitudes to adverse drug-reaction reporting. Br J Clin Pharmacol 1996, 41:433-5.
Published
How to Cite
Issue
Section

This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
Most read articles by the same author(s)
- VN Vamsi Krishna, Amit Kumar, K Ravi Shankar, Post Covid-19 Complications - A Review , Journal of Clinical and Pharmaceutical Research: JCPR Volume:1/Issue:2 (2021)
- Amit Kumar, VN Vamsi Krishna, M Siva Ganga, U Christine, GSR Surendranath, Prescribing Pattern of Drugs in the Management of Chronic Obstructive Pulmonary Disease at an Indian Tertiary Care Teaching Hospital , Journal of Clinical and Pharmaceutical Research: JCPR Volume:1/Issue:1 (2021)
- A Narendranath, VN Vamsi Krishna, J Akhila, A Brief Review on Covid-19 Vaccines , Journal of Clinical and Pharmaceutical Research: JCPR Volume:2/Issue:1 (2022)

.